Business
Eli Lilly Acquires Vaccine Developers
Eli Lilly is acquiring three small vaccine developers, expanding its work in infectious diseases and boosting the field.
Coverage timeline — 1 article
MarketWatch
Spiking S&P 500 profits often signal the final innings of a bull market. History says stocks are on thin ice.
2026-05-26 11:23 UTC